Abstracto In November 2015 the CALYM Carnot Institute held a two-day workshop to discuss the current and future development of immunomodulatory antibodies for the treatment of lymphoma. Highlights from the workshop are presented in this article.
autores Houot, Roch Gaulard, Philippe Schreiber, Robert Mellman, Ira Lambotte, Olivier Coulie, Pierre G. Fest, Thierry Korman, Alan Levy, Ronald Shipp, Margaret Tarte, Karin Kohrt, Holbrook Marabelle, Aurelien Ansell, Stephen Watier, Hervé Van Elsas, Andrea Balakumaran, Arun Arce Vargas, Frederick Quezada, Sergio A. Salles, Gilles Olive, Daniel